95% CI 0.07 to 0.04
Which almost never happens, especially in a journal as prestigious as PNAS (Delaye
Its yet another way Housewives viewership trains the discerning cultural critic to see the writing on the wall: things are going to get very messy, very quickly, and at the end of it all, we will have no more grace for the people struggling with their weight and body image issues
References Kovesdy CP
For instance, liraglutide (Victoza), dulaglutide (Trulicity), and subcutaneous semaglutide (Ozempic) have data supporting risk reduction of major adverse cardiovascular events as well as preserving kidney function in patients with T2DM.(2)(3)(4) Another benefit of GLP-1 and GIP/GLP-1 receptor agonists is significant weight loss, specifically seen with liraglutide, semaglutide, and tirzepatide, which are now available as FDA approved products for weight management with the brand names Saxenda, Wegovy, and Zepbond respectively.(5)(6)(7) While these products have great glycemic, weight, and cardiovascular outcomes, the benefits have resulted in some detrimental repercussions
